- Home
- AN vs KNSA Comparison
AN vs KNSA Comparison
Compare AN & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AN | KNSA |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.9B |
| IPO Year | 1995 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AN | KNSA |
|---|---|---|
| Price | $155.41 | $77.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $233.33 | $98.00 |
| AVG Volume (30 Days) | ★ 621.9K | 425.3K |
| Earning Date | 10-22-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.71 | ★ 225.00 |
| EPS | ★ 11.26 | 0.27 |
| Revenue | ★ $27,631,400,000.00 | $677,564,000.00 |
| Revenue This Year | $0.41 | $46.66 |
| Revenue Next Year | $3.53 | $22.90 |
| P/E Ratio | ★ $14.02 | $286.00 |
| Revenue Growth | 3.24 | ★ 60.09 |
| 52 Week Low | $153.46 | $35.53 |
| 52 Week High | $235.81 | $82.94 |
Technical Indicators
Market Signals| Indicator | AN | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 27.93 | 53.01 |
| Support Level | N/A | $74.47 |
| Resistance Level | $213.29 | $81.42 |
| Average True Range (ATR) | 8.01 | 2.59 |
| MACD | -1.01 | -0.06 |
| Stochastic Oscillator | 4.25 | 62.69 |
Price Performance
Historical ComparisonAbout AN AutoNation Inc.
AutoNation is the second-largest automotive dealer in the United States, with 2025 revenue of $27.6 billion and over 245 dealerships, plus 52 collision centers. The firm also has 24 AutoNation USA used-vehicle stores, a captive lender, four auction sites, and three parts distributors across 20 states primarily in Sunbelt metropolitan areas. New-vehicle sales account for nearly half of revenue; the company also sells used vehicles, parts, and repair services as well as auto financing. The company (formerly Republic Industries) divested its waste management unit (Republic Services) in 1999 and its car rental businesses (ANC Rental) in 2000. Wayne Huizenga founded the company in the 1990s to bring the rollup acquisition strategy to auto retailing, which proved to be a smart move.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.